Efficacy and safety of pralsetinib in patients with RET fusion positive non-small cell lung cancer: An observational real world study. Liao D, Long M, Zhang J, Wei X, et al. Lung Cancer 2024;196:107936.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liao D, Long M, Zhang J, Wei X, et al. Efficacy and safety of pralsetinib in patients with RET fusion positive non-small cell lung cancer: An observational real world study. Lung Cancer 2024;196:107936.
PMID: 39241296